EOF
Asset Logo

Ecofibre Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ“ฆ LOGISTICS

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-19.74%
Annual Growth

5 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

7
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Ecofibre Ltd. engages in the research, production, and sale of polymer-based industrial products, and hemp derived nutraceuticals and food. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-03-29. The company also owns interest in a life sciences business that is developing treatments for malignant and non-malignant gynecological diseases. Its segments include Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, Ecofibre Corporate, and EOF Bio Inc. Ecofibre Advanced Technologies segment is engaged in advanced manufacturing business in performance yarn extrusion, polymer compounding and textiles manufactured in the United States. Ananda Health segment is engaged in the production and sale of hemp related and other nutraceutical products in the United States and Australia. Ecofibre Genetics segment is engaged in the supply of seed genetics to the hemp fiber and grain industry in the United States and Australia. Ecofibre Corporate segment is engaged in group corporate and shared service functions.

๐Ÿ“ˆ Performance

Price History

-96.60%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.03

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in EOF

7

๐Ÿ“Š Total Capital Earnings

$2K

๐Ÿ”ƒ Average investment frequency

18 weeks

๐Ÿ’ต Average investment amount

$332

โฐ Last time a customer invested in EOF

3 hours
EOF investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

57%

50k - 100k

14%

Less than 50k

29%
๐Ÿ‘ถ Age of investors

18 - 25

14%

26 - 34

43%

35 - 90

43%
๐Ÿ™‹ Legal gender of investors

Female

29%

Male

71%

Pearlers who invest in EOF also invest in...

Incannex Healthcare Limited

IHL

Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The firm is engaged in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The firm targets five indications: obstructive sleep apnea (OSA), traumatic brain injury and concussion (TBI), rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and inflammatory lung conditions. Its drug candidates include IHL-42X, IHL-216A, Psilocybin-assisted psychotherapy for general anxiety disorder (Psi-GAD) and IHL-675A. Its IHL-42X is a cannabinoid combination product for treatment of OSA. Its IHL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. IHL-216A is a cannabinoid combination product for the treatment of TBI. The company is investigating the use of psilocybin-assisted psychotherapy to treat GAD.

๐Ÿ™Œ Performance (5Yr p.a)

21.00%

๐Ÿ“Š Share price

$0.04 AUD

NULL STOCK

Find Out More

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. Its principal activities include the cultivation of medicinal cannabis, procurement of raw materials and production of medicinal cannabis medicines; the supply of medicinal cannabis products into Australia and Europe; the supply of medicinal cannabis products for observational and clinical studies and research and development of new medicinal cannabis products, and the development of a psychedelics business including sponsoring a clinical trial into the treatment of refractory depression with psilocybin assisted therapy, construction of a psilocybin mushroom cultivation facility, and establishment of a psychedelic treatment clinic. The company has two global production sites for the manufacture of its own-branded and white-label ranges medicinal cannabis products.

๐Ÿ“Š Share price

$0.13 AUD

๐Ÿ“ฆ LOGISTICS

Cann Group Ltd. engages in the cultivation of medicinal cannabis and further processing into manufactured medicinal cannabis products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The company operates through cultivation of the medicinal cannabis segment. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation, and good manufacturing practices (GMP) manufacturing facilities are in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

๐Ÿ™Œ Performance (5Yr p.a)

-18.23%

๐Ÿ“Š Share price

$0.04 AUD

๐Ÿ“ฆ LOGISTICS

Adore Beauty Group Ltd. engages in the marketing and retailing of beauty care products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-10-23. The firm is an integrated content, marketing and electronic commerce retail platform that partners with beauty and personal care brands. Its product categories include skincare, make up, hair, fragrance and wellness. Its skin care products include cosmeceuticals, serums and treatments, moisturizers, cleansers, exfoliators and masks. The firm's makeup products include foundation, concealer, global shades, primer, powder, setting spray, blush and highlighters. The firm's hair products include shampoo, conditioner, scalp scrubs, dry shampoo, treatments, hair color, hair supplements, hairbrushes and tools, hair accessories, hair concern and blonde hair. Its fragrance products include home fragrance, the scent room, and fragranced hand and body care. The firm's wellness products include face sculpting tool, face roller, face mask, tongue cleaner and eye mask.

๐Ÿ“Š Share price

$0.90 AUD

๐Ÿ›๏ธ CONSUMER

ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)

๐Ÿ™Œ Performance (5Yr p.a)

4.81%

๐Ÿ“Š Share price

$78.23 AUD

๐ŸŒ GLOBAL

๐Ÿค– TECHNOLOGY

๐Ÿญ INDUSTRIALS

Want more shares? Try these...

Energy One Ltd. engages in the business of supplying and developing software and services to energy companies and utilities. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2007-01-15. The Companyโ€™s principal activity is the development and supply of software and services as well as energy trading and associated advisory services to energy companies and utilities. The Companyโ€™s segments include Energy Software and Energy Trading Industry. Its geographical segments include Australasia, CQ Energy and the United Kingdom /Europe. The Companyโ€™s software and services include advisory services, demand-linked risk management solutions, egssPort, EnergyOffer, enFlow, enPrice, enTrader, enVoy, EOT, eZ-Ops, generation services, NemSight, managed services, pypIT, SimEnergy, plant outage insurance, weather-linked risk management solutions, and global 24/7 outsourced operations services. The company serves a range of customers across the globe, including energy retailers, generators, users, customers.

๐Ÿ™Œ Performance (5Yr p.a)

39.60%

๐Ÿ“Š Share price

$6.84 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

Electro Optic Systems Holdings Ltd. develops and produces products incorporating advanced electro-optic technologies for the aerospace market. The company operates in two divisions: Defence Systems and Space Systems. The Defence Systems division specializes in technology for weapon systems optimization and integration, as well as ISR (Intelligence, Surveillance and Reconnaissance) and C4 systems for land warfare. Its key products include remote weapon systems, vehicle turrets, high-energy laser weapons (directed energy), as well as fully integrated and modular counter-UAS and C4 systems. The Space Systems division includes all EOS space and communications businesses, and operates as two entities, Space Technologies, and EM Solutions. Space Technologies specializes in applying EOS-developed optical sensors and effectors to detect, track and characterize objects in space. EM Solutions delivers radio frequency (RF) and optical space communications technology.

๐Ÿ™Œ Performance (5Yr p.a)

-16.73%

๐Ÿ“Š Share price

$1.18 AUD

๐Ÿš€ AEROSPACE & DEFENSE

๐Ÿ“Š Share price

$0.00 AUD

Enegex Ltd. engages in the exploration, evaluation, and investment of natural resources. The principal activity of the Company includes natural resources exploration, evaluation and investment. The firm's West Yilgarn projects cover approximately 2,942 square kilometers (km2), all within 200 kilometers (km). Its West Yilgarn tenements is divided into five project areas: Perenjori, Miamoon, Walebing, Goomalling and Green Hills. The Perenjori Project is situated to the north of Miamoon and covers several northwest trending aeromagnetic and gravity corridors thought to be the continuation of the gneiss and partially preserved greenstone terrain in the Miamoon and eastern Walebing areas. The Miamoon project comprises five exploration licenses (E70/5446, E70/5457, E70/5458, E70/5460 and E70/5463). The Walebing project includes five exploration licenses (E70/5439, E70/5440, E70/5441, E70/5442 and E70/5631).

๐Ÿ™Œ Performance (5Yr p.a)

15.14%

๐Ÿ“Š Share price

$0.01 AUD

โ›๏ธ MINING

๐Ÿ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist